Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Real-Time Polymerase Chain Reaction | 5 | 2014 | 273 | 1.120 |
Why?
|
| beta-Lactamases | 3 | 2013 | 52 | 0.940 |
Why?
|
| Polymerase Chain Reaction | 10 | 2020 | 927 | 0.900 |
Why?
|
| DNA Primers | 5 | 2011 | 543 | 0.510 |
Why?
|
| Bacteriological Techniques | 2 | 2012 | 39 | 0.510 |
Why?
|
| Klebsiella Infections | 2 | 2012 | 25 | 0.500 |
Why?
|
| Klebsiella pneumoniae | 2 | 2012 | 34 | 0.500 |
Why?
|
| Neonatal Sepsis | 2 | 2023 | 3 | 0.440 |
Why?
|
| Anal Canal | 1 | 2013 | 89 | 0.440 |
Why?
|
| Bacteria | 2 | 2023 | 447 | 0.400 |
Why?
|
| Transforming Growth Factor beta | 3 | 2020 | 301 | 0.370 |
Why?
|
| DNA, Bacterial | 4 | 2020 | 236 | 0.370 |
Why?
|
| Oncolytic Virotherapy | 2 | 2020 | 41 | 0.360 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2009 | 45 | 0.350 |
Why?
|
| BRCA2 Protein | 1 | 2009 | 158 | 0.330 |
Why?
|
| Adenoviridae | 2 | 2020 | 345 | 0.330 |
Why?
|
| BRCA1 Protein | 1 | 2009 | 200 | 0.320 |
Why?
|
| Pancreatic Neoplasms | 7 | 2014 | 645 | 0.310 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2007 | 16 | 0.300 |
Why?
|
| Mutation | 6 | 2018 | 3968 | 0.290 |
Why?
|
| Plasmodium | 1 | 2005 | 10 | 0.270 |
Why?
|
| Malaria | 1 | 2005 | 23 | 0.260 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2010 | 102 | 0.260 |
Why?
|
| Genes, ras | 5 | 1995 | 96 | 0.210 |
Why?
|
| Bone Neoplasms | 2 | 2020 | 322 | 0.210 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2022 | 71 | 0.200 |
Why?
|
| Umbilical Cord | 1 | 2021 | 40 | 0.200 |
Why?
|
| Genetic Vectors | 2 | 2020 | 439 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2020 | 5 | 0.190 |
Why?
|
| Sepsis | 1 | 2023 | 306 | 0.180 |
Why?
|
| Oncolytic Viruses | 1 | 2019 | 23 | 0.180 |
Why?
|
| Gene Amplification | 2 | 2018 | 131 | 0.170 |
Why?
|
| Tuberculosis | 1 | 2020 | 110 | 0.170 |
Why?
|
| Immunity | 1 | 2019 | 136 | 0.160 |
Why?
|
| Humans | 29 | 2023 | 86643 | 0.160 |
Why?
|
| Staphylococcal Infections | 2 | 2014 | 255 | 0.160 |
Why?
|
| Pancreatic Ducts | 2 | 1994 | 26 | 0.150 |
Why?
|
| Influenza, Human | 2 | 2010 | 329 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2021 | 534 | 0.140 |
Why?
|
| Sensitivity and Specificity | 4 | 2014 | 1991 | 0.130 |
Why?
|
| Prevalence | 2 | 2023 | 1239 | 0.130 |
Why?
|
| Point Mutation | 2 | 2013 | 246 | 0.130 |
Why?
|
| Bone Marrow Cells | 2 | 2006 | 253 | 0.130 |
Why?
|
| Base Sequence | 6 | 2007 | 2330 | 0.120 |
Why?
|
| Paraffin Embedding | 2 | 2013 | 78 | 0.120 |
Why?
|
| Formaldehyde | 2 | 2013 | 52 | 0.120 |
Why?
|
| Pancreatectomy | 1 | 2014 | 148 | 0.120 |
Why?
|
| RNA, Ribosomal, 23S | 1 | 2013 | 4 | 0.120 |
Why?
|
| Clarithromycin | 1 | 2013 | 7 | 0.120 |
Why?
|
| Epidemiological Monitoring | 1 | 2013 | 39 | 0.120 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 73 | 0.110 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2013 | 36 | 0.110 |
Why?
|
| Prostatic Neoplasms | 3 | 2013 | 1721 | 0.110 |
Why?
|
| Helicobacter Infections | 1 | 2013 | 34 | 0.110 |
Why?
|
| Gastritis | 1 | 2013 | 32 | 0.110 |
Why?
|
| Helicobacter pylori | 1 | 2013 | 35 | 0.110 |
Why?
|
| Nucleic Acids | 1 | 2013 | 30 | 0.110 |
Why?
|
| Neuroendocrine Tumors | 1 | 2014 | 105 | 0.110 |
Why?
|
| Long-Term Care | 1 | 2013 | 61 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1995 | 427 | 0.110 |
Why?
|
| Oncogenes | 2 | 1995 | 88 | 0.110 |
Why?
|
| Thyroid Diseases | 1 | 2013 | 104 | 0.110 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2013 | 71 | 0.110 |
Why?
|
| Endothelial Cells | 2 | 2006 | 428 | 0.110 |
Why?
|
| Thyroidectomy | 1 | 2013 | 170 | 0.110 |
Why?
|
| Stomach | 1 | 2013 | 108 | 0.110 |
Why?
|
| DNA Mutational Analysis | 2 | 2013 | 526 | 0.110 |
Why?
|
| Culture Media | 1 | 2012 | 147 | 0.110 |
Why?
|
| Adenoma, Islet Cell | 1 | 1992 | 28 | 0.110 |
Why?
|
| Rodentia | 1 | 1992 | 42 | 0.100 |
Why?
|
| Biomarkers, Tumor | 2 | 2022 | 1464 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 736 | 0.100 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 263 | 0.100 |
Why?
|
| Adenocarcinoma | 3 | 2013 | 1169 | 0.100 |
Why?
|
| Virology | 1 | 2010 | 9 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 938 | 0.090 |
Why?
|
| Neoplasms | 2 | 2022 | 2898 | 0.090 |
Why?
|
| Viral Matrix Proteins | 1 | 2009 | 14 | 0.090 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2010 | 80 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2010 | 69 | 0.090 |
Why?
|
| Robotics | 1 | 2013 | 267 | 0.090 |
Why?
|
| Influenza A virus | 1 | 2010 | 169 | 0.090 |
Why?
|
| Prostatectomy | 1 | 2013 | 471 | 0.090 |
Why?
|
| Infant, Newborn | 3 | 2023 | 2379 | 0.090 |
Why?
|
| Genes, BRCA2 | 1 | 2009 | 160 | 0.080 |
Why?
|
| Genes, BRCA1 | 1 | 2009 | 192 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 458 | 0.080 |
Why?
|
| Species Specificity | 2 | 2007 | 678 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 746 | 0.080 |
Why?
|
| Chlamydophila psittaci | 1 | 2007 | 2 | 0.080 |
Why?
|
| Eye Neoplasms | 1 | 2007 | 27 | 0.080 |
Why?
|
| DNA | 2 | 2009 | 1294 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2023 | 8489 | 0.080 |
Why?
|
| Chlamydia Infections | 1 | 2007 | 25 | 0.070 |
Why?
|
| RNA, Viral | 2 | 2023 | 327 | 0.070 |
Why?
|
| Female | 10 | 2023 | 44532 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 2903 | 0.070 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2006 | 40 | 0.070 |
Why?
|
| Middle Aged | 8 | 2020 | 25028 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2012 | 864 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 1686 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2013 | 754 | 0.070 |
Why?
|
| Animals | 10 | 2020 | 26582 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 819 | 0.070 |
Why?
|
| Liver | 1 | 1991 | 1230 | 0.070 |
Why?
|
| Staphylococcus | 1 | 2005 | 24 | 0.070 |
Why?
|
| DNA, Protozoan | 1 | 2005 | 16 | 0.070 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2005 | 34 | 0.070 |
Why?
|
| Bacterial Typing Techniques | 1 | 2005 | 28 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 1673 | 0.060 |
Why?
|
| Adult | 7 | 2023 | 25648 | 0.060 |
Why?
|
| Cell Line | 1 | 2009 | 2468 | 0.060 |
Why?
|
| Male | 11 | 2021 | 40965 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 2007 | 3030 | 0.060 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2007 | 261 | 0.060 |
Why?
|
| Genes, p53 | 2 | 1995 | 109 | 0.060 |
Why?
|
| Cell Communication | 1 | 2005 | 194 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 6509 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2005 | 309 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 860 | 0.060 |
Why?
|
| Mesocricetus | 5 | 1995 | 107 | 0.060 |
Why?
|
| Aged | 6 | 2020 | 18415 | 0.060 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 1995 | 157 | 0.060 |
Why?
|
| Autopsy | 1 | 2023 | 116 | 0.060 |
Why?
|
| Cricetinae | 5 | 1995 | 560 | 0.060 |
Why?
|
| Liquid Biopsy | 1 | 2022 | 33 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 879 | 0.050 |
Why?
|
| Placenta | 1 | 2023 | 175 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 2426 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1805 | 0.050 |
Why?
|
| DNA, Neoplasm | 2 | 2013 | 265 | 0.050 |
Why?
|
| Hospitals | 2 | 2013 | 294 | 0.050 |
Why?
|
| Carcinogens | 3 | 1995 | 108 | 0.050 |
Why?
|
| Immunomodulation | 1 | 2019 | 55 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 2232 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2007 | 173 | 0.040 |
Why?
|
| CTLA-4 Antigen | 1 | 2019 | 135 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 153 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 152 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 2705 | 0.040 |
Why?
|
| Class II Phosphatidylinositol 3-Kinases | 1 | 2018 | 8 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 1041 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2020 | 790 | 0.040 |
Why?
|
| Gene Expression | 2 | 1994 | 1284 | 0.040 |
Why?
|
| Mice | 4 | 2020 | 11352 | 0.040 |
Why?
|
| Methylnitrosourea | 2 | 1994 | 7 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 159 | 0.040 |
Why?
|
| Inflammation | 1 | 2023 | 920 | 0.040 |
Why?
|
| Virus Replication | 1 | 2019 | 319 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2018 | 85 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 272 | 0.040 |
Why?
|
| Pandemics | 1 | 2023 | 740 | 0.040 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 185 | 0.040 |
Why?
|
| Pregnancy | 1 | 2023 | 2894 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 1992 | 1197 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 407 | 0.030 |
Why?
|
| Cell Aggregation | 2 | 2006 | 39 | 0.030 |
Why?
|
| Culture Media, Conditioned | 2 | 2006 | 104 | 0.030 |
Why?
|
| Genes, Retinoblastoma | 1 | 1995 | 22 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 776 | 0.030 |
Why?
|
| Keratin-19 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 853 | 0.030 |
Why?
|
| Nitrosourea Compounds | 1 | 1994 | 9 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 64 | 0.030 |
Why?
|
| Child | 2 | 2020 | 6927 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1994 | 50 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 79 | 0.030 |
Why?
|
| Time Factors | 2 | 2012 | 5210 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 5976 | 0.030 |
Why?
|
| Fixatives | 1 | 2013 | 12 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2019 | 3241 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 8981 | 0.030 |
Why?
|
| Electrophoresis | 1 | 2013 | 55 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 3679 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2013 | 40 | 0.030 |
Why?
|
| Exons | 2 | 1995 | 450 | 0.030 |
Why?
|
| Kallikreins | 1 | 2013 | 47 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2013 | 87 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2010 | 3612 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2013 | 69 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2013 | 143 | 0.030 |
Why?
|
| Chromogenic Compounds | 1 | 2012 | 5 | 0.030 |
Why?
|
| Agar | 1 | 2012 | 8 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2013 | 98 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 912 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1384 | 0.030 |
Why?
|
| ROC Curve | 1 | 2014 | 752 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 859 | 0.030 |
Why?
|
| Illinois | 1 | 2013 | 462 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 999 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 1204 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 1992 | 181 | 0.030 |
Why?
|
| Rectum | 1 | 2012 | 146 | 0.020 |
Why?
|
| Trout | 1 | 1991 | 2 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2014 | 814 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 1992 | 196 | 0.020 |
Why?
|
| General Surgery | 1 | 2013 | 229 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2014 | 1538 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2013 | 353 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1995 | 696 | 0.020 |
Why?
|
| Nasopharynx | 1 | 2009 | 47 | 0.020 |
Why?
|
| Introns | 1 | 1991 | 289 | 0.020 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1990 | 113 | 0.020 |
Why?
|
| Adenoma | 1 | 1992 | 235 | 0.020 |
Why?
|
| Biopsy | 1 | 2013 | 1163 | 0.020 |
Why?
|
| Nitrosamines | 3 | 1995 | 8 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 1994 | 2818 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1753 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2767 | 0.020 |
Why?
|
| Mass Screening | 1 | 2012 | 618 | 0.020 |
Why?
|
| Chicago | 1 | 2012 | 1379 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 1981 | 0.020 |
Why?
|
| Chemotactic Factors | 1 | 2005 | 14 | 0.020 |
Why?
|
| Transition Temperature | 1 | 2005 | 9 | 0.020 |
Why?
|
| DNA Probes | 1 | 2005 | 77 | 0.020 |
Why?
|
| Blood | 1 | 2005 | 69 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2005 | 164 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2005 | 94 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2005 | 241 | 0.020 |
Why?
|
| Collagen | 1 | 2005 | 269 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 3046 | 0.010 |
Why?
|
| Cell Division | 1 | 2005 | 696 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 353 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 758 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 1995 | 30 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1995 | 393 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 416 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 646 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1995 | 329 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1992 | 148 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1995 | 645 | 0.010 |
Why?
|